Results
Dexcom Beats EPS, Guidance Miss, Shares Fall
Dexcom reported Q1 adjusted EPS of $0.56, topping the $0.47 consensus by $0.09.
Revenue rose 15% YoY to $1.19 bn, beating the $1.17 bn estimate, while U.S. sales grew 11% and international sales jumpe
